LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 41 filers reported holding LUMOS PHARMA INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $180,500 | – | 50,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Minerva Advisors LLC | 34,015 | $321,000 | 0.21% |
Lion Point Capital, LP | 51,205 | $481,000 | 0.11% |
Wealth Advisors of Iowa, LLC | 11,699 | $110,000 | 0.06% |
NEA Management Company, LLC | 167,608 | $1,575,000 | 0.04% |
Paladin Advisory Group, LLC | 4,382 | $40,000 | 0.03% |
Marquette Asset Management, LLC | 13,315 | $125,000 | 0.03% |
Blackstone Inc. | 468,145 | $4,401,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 47,643 | $450,000 | 0.01% |
Jefferies Group LLC | 120,651 | $1,134,119 | 0.01% |
Renaissance Technologies | 271,712 | $2,554,000 | 0.00% |